Phase 2 B-cell Non-Hodgkin's Lymphoma Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Junshi Bioscience Co., Ltd.180 enrolled1 locationNCT07081022
Recruiting
Phase 1Phase 2
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
High-grade B-cell LymphomaNon-Hodgkin LymphomaLymphoma+12 more
Estrella Biopharma, Inc.21 enrolled2 locationsNCT06343311
Recruiting
Phase 1Phase 2
A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Shanghai Hengrui Pharmaceutical Co., Ltd.132 enrolled1 locationNCT06104553
Recruiting
Phase 2
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
B-cell Non-Hodgkin's Lymphoma
Hrain Biotechnology Co., Ltd.100 enrolled1 locationNCT05436223